Reduced Asthma Exacerbations Seen With Tezepelumab
Reduction seen with three dose levels of tezepelumab regardless of blood eosinophil counts
Budget Cuts Threaten Research on Antimicrobial Resistance
Patient safety, international status of the U.S. as leader in combating AMR both at risk
Docs Should Be Aware of Family Beliefs Regarding Nondisclosure
Evidence from Middle East literature suggests variability in practices, preferences of truth telling
Dupilumab Improves Quality of Life in Atopic Dermatitis
Correlation for QoL scores with changes in efficacy outcomes, including eczema area and severity index
August 2017 Briefing – Allergy
Here are what the editors at HealthDay consider to be the most important developments in Allergy for August 2017. This roundup includes the latest...
Local Allergic Rhinitis Often Progresses Over Time
With increase in emergency care, development of asthma, loss of allergen tolerance, QoL impairment
Minimal Evidence for Electronic Communication Guidelines
Current guidelines for e-communication between patients, providers based on minimal evidence
Many Parents Aren’t Divulging CAM Use to Child’s Provider
Providers urged to regularly inquire about all therapies family is using to care for child
Proactive Approach Encouraged for Online Patient Reviews
Most patients use online reviews as first step to find new doctor; form an opinion from one to six reviews
Low Rate of Recurrence Seen for Serious Reactions to Vaccines
Findings add to evidence of safety of childhood immunizations, pediatricians say
